1 pixel 1 empty pixel
This is a decorative photo newsbg

The Richmond Hill Center for Business Development (CBD) drives collaboration between Canadian based Pro-Lab Diagnostics and Finland based Medicortex, bringing groundbreaking research for early detection of Traumatic Brain Injury (TBI) to Canada

Pro-LabRichmond Hill, May 24, 2018 – The Richmond Hill Center for Business Development (CBD) today announced an Agreement that will see an investment by Richmond Hill-based Pro-Lab Diagnostics into Medicortex, a Finland – based company that is developing a unique biomarker test based on one of the body fluids to determine whether victims have sustained a brain injury as a result of a hit to the head from a fall, a vehicular accident or a sports related activity.
Categorized in: Business, Life Sciences & Health Technology, Partnerships Posted on: Last updated on: Written by:

Pro-LabRichmond Hill, May 24, 2018 – The Richmond Hill Center for Business Development (CBD) today announced an Agreement that will see an investment by Richmond Hill-based Pro-Lab Diagnostics into Medicortex, a Finland – based company that is developing a unique biomarker test based on one of the body fluids to determine whether victims have sustained a brain injury as a result of a hit to the head from a fall, a vehicular accident or a sports related activity. At this time, no accurate and definite diagnostic tool exists for such brain injuries.

Full Article: cbdinc.biz